Table 1.
Correlation between the Proportion of Patients with Ocular Findings and Duration of Disease
| No. | Duration of Disease (days) |
Correlation Coefficient | P Value∗ | |||
|---|---|---|---|---|---|---|
| 1–10 | 11–20 | 21–38 | ||||
| Ocular symptoms, no. (%) | 0.111 | 0.22 | ||||
| Yes | 8 | 1 (12.5) | 4 (50.0) | 3 (37.5) | ||
| No | 113 | 45 (39.8) | 35 (31.0) | 33 (29.2) | ||
| Conjunctival SARS-CoV-2 detection, no∙ (%) | 0.074 | 0.42 | ||||
| + | 3 | 0 (0.0) | 2 (66.7) | 1 (33.3) | ||
| ± | 4 | 1 (25.0) | 2 (50.0) | 1 (25.0) | ||
| – | 114 | 45 (39.5) | 35 (30.7) | 34 (29.8) | ||
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; + = positive (cycle threshold values, <37); ± = suspicious (cycle threshold values, 37–40); – = negative (no cycle threshold value or cycle threshold values = 40).
Spearman rank correlation analysis.